The fiduciary obligation of the physician-researcher in phase IV trials

BMC Medical Ethics

Volumn 15, Issue 1, 2014, Pages

  Bernabe, Rosemarie D L C ^a   Van Thiel, Ghislaine J M W ^a   Raaijmakers, Jan A M ^b   Van Delden, Johannes J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GLAXOSMITHKLINE   (Netherlands)

Author keywords

Fiduciary obligation; Interventional trials; Phase IV; Physician researchers

Indexed keywords

ARTICLE; ETHICS; FEMALE; HUMAN; HUMAN RELATION; INFORMED CONSENT; MALE; METHODOLOGY; MORALITY; PERSONNEL; PHASE 4 CLINICAL TRIAL (TOPIC); PHYSICIAN; RESEARCH ETHICS; RESEARCH SUBJECT;

CLINICAL TRIALS, PHASE IV AS TOPIC; ETHICS, RESEARCH; FEMALE; HUMANS; INFORMED CONSENT; MALE; MORAL OBLIGATIONS; PHYSICIANS; RESEARCH DESIGN; RESEARCH PERSONNEL; RESEARCH SUBJECTS; RESEARCHER-SUBJECT RELATIONS;

EID: 84893648624     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-15-11     Document Type: Review

References (37)

1. Phase IV research: innovation in need of ethics. van Thiel GJ, van Delden JJ, J Med Ethics 2008 June 34 6 415 416 10.1136/jme.2007.023911
2. CMR International Institute for Regulatory Science, New development paradigms: building regulatory confidence for the early release of medicines 2010 Available at http://cirsci.org/system/files/private/1023-October2010- Workshop.pdf
3. Boessen R, Methods to improve the efficiency of confirmatory clinical trials PhD dissertation, Utrecht University, 2013. Available at http://igitur-archive.library.uu.nl/dissertations/2013-0501-200840/UUindex.html
4. Pharma 2020: the vision. PriceWaterhouseCoopers, 2007 Available at http://www.pwc.com/gx/en/pharma-life-sciences/pharma-2020/pharma-2020-vision- path.jhtml
5. Ethical considerations in studying drug safety-the institute of medicine report. Mello MM, Goodman SN, Faden RR, N Engl J Med 2012 September 6 367 10 959 964 10.1056/NEJMhle1207160
6. Ethical and scientific issues in studying the safety of approved drugs. Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Institute of Medicine of the National Academies 2012 Available at http://www.nap.edu/catalog.php?record-id=13219
7. General considerations for clinical trials E8. International Conference on Harmonisation, 1997 Available at http://www.ich.org/products/guidelines/ efficacy/efficacy-single/article/general-considerations-for-clinical-trials.html
8. Phase IV drug development: post-marketing studies. Johnson-Pratt LR, Principles and Practice of Pharmaceutical Medicine Chichester: John Wiley & Sons, Edwards LD, Fletcher AJ, Fox AW, Stonier PD, 2 2007 119 120
9. Phase IV non-inferiority trials and additional claims of benefit. Bernabe RD, Wangge G, Knol MJ, Klungel OH, van Delden JJ, de Boer A, Hoes AW, Raaijmakers JA, van Thiel GJ, BMC Med Res Methodol 2013 13 70 10.1186/1471-2288-13-70 23721202
10. Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers. Eichler HG, Bloechl-Daum B, Abadie E, Barnett D, Konig F, Pearson S, Nat Rev Drug Discov 2010 9 4 277 291 10.1038/nrd3079 20186141
11. Is informed consent necessary for randomized Phase IV 'observational' drug studies? Bernabe RD, van Thiel GJ, Raaijmakers JA, van Delden JJ, Drug Discov Today 2011 September 16 17-18 751 754
12. The therapeutic orientation to clinical trials. Miller FG, Rosenstein DL, N Engl J Med 2003 April 3 348 14 1383 1386 10.1056/NEJMsb030228 (Pubitemid 36384108)
13. Doctor vs. scientist? Jansen LA, Hastings Cent Rep 2008 March 38 2 3
14. Making research a requirement of treatment: why we should sometimes let doctors pressure patients to participate in research. Orentlicher D, Hastings Cent Rep 2005 September 35 5 20 28 (Pubitemid 43167977)
15. Rethinking the therapeutic obligation in clinical research. Comoretto N, Human Medical Research: Ethical, Legal and Socio-Cultural Aspects Basel: Springer, Schildmann J, Sandow V, Rauprich O, Vollman J, 2012 55 63
16. Commentary: the distinction between research and practice-a response to T. Beauchamp. Verweij MF, J Intern Med 2011 269 4 388 391 10.1111/j.1365-2796. 2011.02350-2.x 21410786
17. The Belmont Report. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979 Available at http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html
18. Clinical ethics versus clinical research. Appelbaum PS, Lidz CW, Am J Bioeth 2006 July 6 4 53 55 10.1080/15265160600755615 (Pubitemid 44181300)
19. Clinical research in context: reexamining the distinction between research and practice. Anderson JA, J Med Philos 2010 February 35 1 46 63 10.1093/jmp/jhp054
20. Equipoise and the ethics of clinical research. Freedman B, N Engl J Med 1987 July 16 317 3 141 145 10.1056/NEJM198707163170304 (Pubitemid 17092151)
21. Avoiding a Jekyll-and-Hyde approach to the ethics of clinical research and practice. Lemmens T, Miller PB, Am J Bioeth 2002 2 2 14 17 10.1162/152651602317533550 12189062
22. Guideline for good clinical practice E6. International Conference on Harmonisation, 1996 Available at http://www.ich.org/products/guidelines/ efficacy/efficacy-single/article/good-clinical-practice.html
23. Good-clinical-practice compliance. European Medicines Agency, 2012 Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/ general/general-content-000072.jsp
24. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. World Medical Association, 2013 Available at http://www.wma.net/en/30publications/10policies/b3/
25. AMA code of ethics. Australian Medical Association, 2006 Available at https://ama.com.au/codeofethics
26. Good medical practice: research. UK General Medical Council, 2012 Available at http://www.gmc-uk.org/guidance/ethical-guidance/5992.asp
27. Fiduciary duties. Frankel T, The New Palgrave Dictionary of Economics and the Law London: Macmillan Press, Newman P, 1998 127 32
28. Fiduciary obligation, law of. Litman MM, The Canadian Encyclopedia 2012 Available at http://www.thecanadianencyclopedia.com/en/article/law-of-fiduciary- obligation/
29. Fiduciary law. Frankel T, California Law Review 1983 71 3 795 836 10.2307/3480303
30. Laura Norberg v. Morris Wynrib. Norberg v. Wynrib Court of Appeal for British Columbia 1992 Available at http://scc-csc.lexum.com/decisia-scc-csc/scc- csc/scc-csc/en/item/893/index.do
31. Medico-legal handbook for physicians in Canada. The Canadian Medical Protective Association 7 2010 Available at https://oplfrpd5.cmpa-acpm.ca/legal- and-regulatory-proceedings/-/asset-publisher/a9unChEc2NP9/content/ a-medico-legal-handbook-for-physicians-in-canada;jsessionid= 762D3B51721B44EBF8201EEB962737F2
32. Legal regulation of the physician-patient relationship. Miller PB, Choudhry S, Campbell A, Royal College of Physicians and Surgeons of Canada 2012 Available at http://www.royalcollege.ca/portal/page/portal/rc/resources/ bioethics/primers/legal-regulation-of-the-physician-patient-relationship
33. The sound of silence: default rules and contractual consent. Barnett R, Virginia Law Review 1992 78 821 911 10.2307/1073344
34. Fiduciary duties as default duties. Frankel T, Oregon Law Review 1995 74 1209 1277
35. Duties to subjects in clinical research. Coleman C, Vanderbilt Law Review 2005 58 2 387 449 (Pubitemid 41640491)
36. Fiduciary obligation in clinical research. Miller PB, Weijer C, J Law Med Ethics 2006 34 2 424 440 10.1111/j.1748-720X.2006.00049.x 16789965 (Pubitemid 43936932)
37. The clinical investigator as fiduciary: discarding a misguided idea. Morreim EH, J Law Med Ethics 2005 33 3 586 598 10.1111/j.1748-720X.2005.tb00521. x 16240738 (Pubitemid 41546092)